TCL Archive NCAB Votes Down Dietary Fat Study In women; Proposal highly Recommended By Study Section September 29, 1989
TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program. May 21, 2004
